Business Context and Reporting Period
Company: Simulations Plus, Inc. (Nasdaq: SLP)
Filing Type: Form 8-K (Current Report)
Date of Filing: June 18, 2025
Reporting Period: Third quarter ended May 31, 2025
Simulations Plus, Inc. is a provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry.
Key Financial Metrics
This filing is a current report regarding an administrative event and does not contain financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The primary material change reported is the rescheduling of the Company's third-quarter financial results release and conference call. The event was previously scheduled for July 2, 2025, and has been moved to utilize the full regulatory timeframe available following the Company's transition from a large accelerated filer to a non-accelerated filer.
Guidance, Outlook, and Management Commentary
- Rescheduled Conference Call: Monday, July 14, 2025, at 5:00 p.m. Eastern Time.
- Financial Results Release: Before market open on Tuesday, July 15, 2025 (the filing deadline).
- Reason for Delay: The Company is utilizing the maximum time allowed by regulation due to its recent change in filer status.
- Risks and Contingencies: No specific risks or contingencies were detailed in this filing beyond the administrative delay.
Important Facts for Investors to Verify
- Verify the new date for the Q3 2025 earnings release (July 15, 2025) and conference call (July 14, 2025).
- Confirm the Company's current filer status (non-accelerated filer) and how this impacts future reporting deadlines.
- Monitor the upcoming press release and 10-Q filing for actual financial performance data, which is not included in this 8-K.